Renal and metabolic clearances of sulfamethoxazole in Mexican healthy subjects
Aguilar-Cota, M.E.; Flores-Murrieta, F.J.; Menéndez, J.C.; Hong, E.; Castañeda-Hernández, G.
Proceedings of the Western Pharmacology Society 35: 103-106
1992
ISSN/ISBN: 0083-8969 PMID: 1502208 Document Number: 400281
Document emailed within 1 workday
Related Documents
Carrasco-Portugal, M.C.; Granados-Soto, V.; Reyes-García, G.; Medina-Santillán, R.; Herrera, J.E.; Flores-Murrieta, F.J. 2001: Multiple-dose pharmacokinetics of fluoxetine in healthy Mexican subjects Proceedings of the Western Pharmacology Society 44: 69-70Kaufman, A.M.; Hellman, G.; Abramson, R.G. 1983: Renal salt wasting and metabolic acidosis with trimethoprim-sulfamethoxazole therapy Mount Sinai Journal of Medicine new York 50(3): 238-239
Tzamaloukas, A.H.; Murata, G.H.; Malhotra, D.; Rao, P.; Piraino, B.; Bernardini, J.; Oreopoulos, D.G. 1999: Small-solute clearances in diabetic subjects on continuous ambulatory peritoneal dialysis: comparison to nondiabetic subjects Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 15: 179-182
Hirsch, S.; Barrera, G.; Gattás, V.; Bunout, D.; Uauy, R. 1986: Metabolic balance of an enteral feeding formula in healthy subjects Revista Medica de Chile 114(8): 719-724
Herrmann, W.; Reuter, W.; Schütz, C.; Herbst, A.; Würzberger, G. 1981: Lipoprotein lipase activity in healthy subjects and patients with metabolic disorders Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 36(7): 298-301
Bunker, V.W.; Lawson, M.S.; Delves, H.T.; Clayton, B.E. 1982: Metabolic balance studies for zinc and nitrogen in healthy elderly subjects Human Nutrition. Clinical Nutrition 36(3): 213-221
Mioli, V.; Vangelista, ' A.; Albertazzi, A.; Bortolotti, G.C.; Bonomini, V. 1974: Renal effects of cephacetrile in man, in healthy and diseased subjects Arzneimittel-Forschung 24(9b): 1504-1505
Ceremuzynski, L.; Zaleska, T.; Nauman, J.; Nauman, A.; Zalewski, A. 1979: Effects of beta-blocking agent Metipranolol on metabolic variables in patients with ischemic heart disease, hyperkinetic syndrome, hyperthyreosis and in healthy subjects International Journal of Clinical Pharmacology and Biopharmacy 17(6): 244-249
Flor, S.; Guay, D.; Opsahl, J.; Tack, K.; Matzke, G. 1991: Pharmacokinetics of ofloxacin in healthy subjects and patients with varying degrees of renal impairment International Journal of Clinical Pharmacology Research 11(3): 115-121
Premel-Cabic, A.; Chaleil, D.; Bonniot, R.; Riberi, P.; Streichenberger, G.; Allain, P. 1981: Comparative study of alminoprofene elimination in healthy subjects and in patients with renal or hepatic insufficiency Therapie 36(1): 41-46
Weiler, H.; Weiler, C.; Gerok, W. 1990: Gastric mucosal prostaglandin E2 levels in gastric non-ulcer and ulcer patients with chronic renal failure or without renal disease, and in healthy subjects Netherlands Journal of Medicine 37(5-6): 189-196
Bernardi, P.; Bastagli, L.; Pecoraro, F.; Vitolo, A.; Minelli, C.; Cavazza, M.; Adani, C. 1982: Effect, on renal function, of a product rich in polyunsaturated fatty acids: results obtained in healthy subjects Bollettino della Societa Italiana di Biologia Sperimentale 58(1-2): 55-59
Roxe, D.M. 1981: Current status of renal clearances Annals of Clinical and Laboratory Science 11(3): 279-282
Rocci, M.L.; Kosoglou, T.; Ferguson, R.K.; Vlasses, P.H. 1989: Ranitidine-induced changes in the renal and hepatic clearances of procainamide are correlated Journal of Pharmacology and Experimental Therapeutics 248(3): 923-928
Golda, V.; Pastrnák, A. 1975: Evoked cortical activity in the healthy human subjects and in the neurosurgical patients. III. Plastic processes of CNS in the picture of the cortical visual evoked potentials and the repetitive after-discharges in the healthy human subjects Sbornik Vedeckych Praci Lekarske Fakulty Karlovy University V Hradci Kralove 18(4-5): 267-282
Bisaccia, C.; De Santo, L.S.; De Santo, N.G.; Ambard, Léon. 2018: Léon Ambard (1876-1962): his priority in using urea as a tool for assessment of kidney function in healthy subjects and in patients undergoing renal surgery Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 35(Suppl. 70): 23-28
Mirouze, J.; Jullien, C.; Monnier, L.; Olivier, C. 1974: Effects of diazoxide, clonidine and a new alpha-blocking agent on renal clearances Clinical Nephrology 2(5): 191-196
Edwards, B.R.; Stern, P. 1977: Renal clearances of 14C-inulin and polyfructosan in the rat. Effect of increased ureteral pressure Pflugers Archiv: European Journal of Physiology 369(3): 281-283
Blainey, J.D.; Terry, J.M. 1979: Urinary fibrinogen degradation products and differential protein clearances in renal disease Clinical Nephrology 11(3): 140-141
Jacob, M.; Causse, J.; Gaudy, D.; Duru, C.; Causse, J.B.; Puech, A. 1982: Diffusion of the drug combination sulfamethoxazole-trimethoprim. Microdetermination in the perilymph, blood and urine of subjects with otosclerosis Pharmaceutica Acta Helvetiae 57(3): 93-96